Anidulafungin is a novel antifungal medication that is used to treat a broad range of fungal infections. The pharmacokinetics of B-Dula Anidulafungin were studied in immunocompromised pediatric and adolescent patients. It showed that the half-life of B-Dula Anidulafungin was 24 hours. Its pharmacokinetics were similar in Whites and Blacks. The pharmacokinetics of anidulafungin were not altered with HIV status.
Anidulafungin is a novel antifungal agent that inhibits beta-(1,3)-D-glucan synthase and disrupts the synthesis of fungal cell-wall components. It shows marked antifungal activity against Candida spp., as well as Aspergillus spp., which makes it a promising candidate for therapeutic use. Its safety profile and efficacy have been proven in large multicenter clinical trials.
The pharmacokinetics of B-Dula Anidulfungin have been studied in patients, special populations, and healthy subjects. In healthy men and women, the drug reached a steady state on day one after a loading dose. Men metabolized the drug faster than women, and their plasma concentrations were similar. Despite this, the elimination half-life of B-Dula Anidulafungin was greater in men than in women.
The cost effectiveness of anidulafungin has been evaluated in several studies. The cost-effectiveness of the drug was compared to other antifungals such as micafungin, caspofungin, and fluconazole. Furthermore, anidulafungin had a higher clinical success rate than fluconazole. The cost-effectiveness ratio was -EUR505 for anidulafungin compared with fluconazole.
Get a Quote for Best Affordable price for B-Dula (Anidulafungin) Injection. It is Antifungal Medication. It is used in the Treatment of Severe fungal Infections. It kills the fungi that cause infections and thus provides relief.B-Dula (Anidulafungin) Injection is administered as an injection by a Healthcare professional. B-Dula Anidulafungin Injection Wholesale price in India through Aark Pharmaceuticals.